Covalis Capital’s Innovid Corp. CTV Stock Holding History

Covalis Capital’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$395K	–	134
2021 Q2	$395K	Buy	+40,000	New	+$400K	0.13%	81

Other funds holding CTV

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Covalis Capital's CTV Position: Q3 2021 in Review

Covalis Capital sold out of Innovid Corp. (CTV) in Q3 2021, closing a stake of 40,000 shares — an estimated $395K sold.

Covalis Capital first reported a position in CTV in Q2 2021 and held it in 1 quarter. The position peaked at $395K in Q2 2021. 71 funds tracked by Wall St. Rank hold CTV as of Q3 2021.

Covalis Capital reported no remaining Innovid Corp. position as of Q3 2021 after selling out during the quarter.
Covalis Capital sold 40,000 Innovid Corp. shares in Q3 2021, an estimated $395K.
Covalis Capital first reported a position in Innovid Corp. in Q2 2021 and held it in 1 quarter.
Covalis Capital's Innovid Corp. position peaked at $395K in Q2 2021.
71 funds tracked by Wall St. Rank held Innovid Corp. as of Q3 2021.

Based on Covalis Capital's 13F filing for Q3 2021, filed 15 Nov 2021.